We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
The EURO STOXX 50 Index is up 67.64 points or 1.36% this week to 5051.31 --Largest one week point and percentage gain since the week ending May 10, 2024 --Today it is down 17.78 points or 0.35% --Off ...
SUPPLY AND DEMAND: OPEC+'s plan to gradually unwind voluntary output curbs of 2.2 million barrels a day from October 2024 to September 2025 led to a sharp fall in oil prices amid concerns over supply ...
Thermo Fisher Scientific Inc. (TMO) is currently at $584.75, up $4.91 or 0.85% --Would be highest close since May 23, 2024, when it closed at $585.03 --Currently up six consecutive days; up 3.91% over ...
Saab AB Series B was the biggest leader among large stocks during the session, rising 9.4%, and Sectra AB Series B gained 6.2%. Clas Ohlson AB Series B rounded out the top three leaders on Friday, ...
Toronto-listed stocks were firmly lower mid-trading on Friday. Sector performance was mixed, with sharp declines in materials stocks tipping the indexes. Health-services stocks and utilities were also ...
--On pace for largest percent decrease since June 8, 2023, when it fell 5.01% --Currently down three consecutive days; down 7.07% over this period --Worst three day stretch since the three days ending ...
Sherwin-Williams Company (SHW) is currently at $291.12, down $12.94 or 4.26% --Would be lowest close since Dec. 8, 2023, when it closed at $289.82 --On pace for largest percent decrease since March 22 ...
The KOSPI Composite Index is up 86.15 points or 3.27% this week to 2722.67 --Largest one-week point and percentage gain since the week ending Feb. 2, 2024 --Today it is up 33.17 points or 1.23% ...
The Shanghai Composite Index is down 35.53 points or 1.15% this week to 3051.28 --Largest four-week point and percentage decline since the week ending Feb. 2, 2024 ...
Shares of Geron were sharply higher in premarket trading Friday after the biopharmaceutical company won Food and Drug Administration approval of its blood-disorder drug Rytelo.